Skip to main content
. 2021 Nov 23;4(11):e2134969. doi: 10.1001/jamanetworkopen.2021.34969

Table 1. Baseline Characteristics of Participants With Positive and Negative SARS-CoV-2 Test Results According to Psychiatric Diagnostic Categories.

Characteristic Participants, No. (%)
Total (N = 2 535 098) Schizophrenia (1.23% of population) Mood disorders (9.74% of population) Anxiety disorders (6.10% of population) Reference group (74.48% of population)
COVID+ (n = 3350) COVID (n = 30 610) COVID+ (n = 26 610) COVID (n = 243 234) COVID+ (n = 18 856) COVID (n = 149 991) COVID+ (n = 245 601) COVID (n = 1 816 846)
% Of total NA 0.12 1.11 0.96 8.78 0.68 5.42 8.87 65.61
Positivity rate, % 11.61 9.86 NA 9.86 NA 11.17 NA 11.91 NA
Gender
Female 1 580 703 (62) 1845 (55) 16 739 (55) 19 221 (72) 175 956 (72) 12 900 (68) 103 450 (69) 124 403 (51) 968 642 (53)
Male 1 185 282 (38) 1504 (45) 13 850 (45) 7375 (28) 67 083 (28) 5944 (32) 46 460 (31) 120 929 (49) 845 841 (47)
Age, mean (SD), y 44 (22) 57 (19) 54 (18) 50 (19) 50 (18) 48 (18) 50 (19) 43 (21) 44 (23)
Race and ethnicity, No.
African American Hispanic 6412 10 102 107 526 50 292 959 4366
African American not Hispanic 233 519 609 5339 2217 17 730 1371 8834 28 927 168 492
African American unknown 20 404 38 269 108 1072 50 534 2308 16 025
Asian Hispanic 790 1 3 9 43 5 33 122 574
Asian not Hispanic 45 689 29 261 168 1385 119 1147 4844 37 736
Asian unknown 5105 4 13 11 118 15 76 479 4389
Caucasian Hispanic 72 454 133 975 926 5414 640 3249 11 762 49 355
Caucasian not Hispanic 1 583 440 2173 20 452 19 897 188 432 14 562 119 509 130 901 1 087 514
Caucasian unknown 157 802 115 1362 900 13 694 571 7475 11 955 121 730
Other or unknowna 105 805 238 3289 2267 14 820 2980 10 017 53 344 326 665
% Caucasian 72 72 74 82 85 84 87 63 69
Current smoker 389 120 (15) 800 (24) 11 890 (39) 3897 (15) 62 111 (26) 2285 (12) 30 364 (20) 17 908 (7) 216 635 (12)
Chronic health conditions
Hypertension 427 328 (17) 1337 (40) 10 784 (35) 5942 (22) 59 535 (24) 3416 (18) 32 329 (22) 29 252 (12) 230 156 (13)
Diabetes 203 400 (8) 856 (40) 6340 (21) 3509 (13) 31 624 (13) 1687 (9) 14 437 (10) 15 912 (6) 101 092 (5)
BMI ≥25 1 099 937 (43) 1208 (36) 12 069 (39) 11 179 (42) 109 406 (45) 7272 (39) 61 151 (41) 98 240 (40) 799 412 (44)
COPD 125 116 (5) 623 (18) 5651 (18) 2141 (8) 24 780 (10) 1014 (5) 11 952 (8) 5331 (2) 54 311 (0.3)
Ischemic heart disease 445 844 (18) 1638 (49) 13 644 (45) 6696 (25) 63 908 (26) 4007 (21) 34 997 (23) 27 807 (11) 233 650 (13)
Metabolic syndrome 32 825 (1) 129 (4) 1043 (3) 892 (3) 7537 (3) 447 (2) 3297 (2) 1956 (0.7) 12 588 (0.7)
Current psychiatric medications
Antidepressants NA 1216 (36) 11 937 (39) 17 859 (67) 166 939 (69) 8332 (44) 67 639 (45) 0 0
Antipsychotics NA 1065 (32) 10 489 (34) 3314 (12) 38 003 (16) 641 (3) 6769 (4) 0 0
Tested at an inpatient facility
Inpatient NA 873 (26) 7622 (25) 3219 (12) 36 585 (15) 1545 (8) 16 643 (11) 26 693 (11) 214 748 (12)
Inpatient psychiatric facility NA 107 (3) 2025 (7) 191 (0.7) 4209 (2) 49 (0.2) 873 (0.5) 531 (0.2) 5909 (0.3)
Died in 2020 post COVID for COVID + or died in 2020 for COVID − 42 153 287 1075 910 4915 454 2431 5899 26 182
Rate of death, % 1.66 8.57 3.51 3.42 2.02 2.41 1.62 2.40 1.44

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); COPD, chronic obstructive pulmonary disease; COVID −, tested negative for COVID-19; COVID +, tested positive for COVID-19; NA, not applicable.

a

Data provided race as African American, Asian, Caucasian, other/unknown. Ethnicity was Hispanic, Not Hispanic, and unknown.